ZTS Q4 2017 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.5B+14.3% YoY

Gross Profit

$980M67.1% margin

Operating Income

$509M34.9% margin

Net Income

$81M5.5% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

$608M

Free Cash Flow

$525M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$8.6B

Total Liabilities

$6.8B

Stockholders' Equity

$1.8B

Cash & Equivalents

$1.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.3B	+14.3%
Gross Profit	$980M	$790M	+24.1%
Operating Income	$509M	$321M	+58.6%
Net Income	$81M	$154M	-47.4%

Revenue Segments

Cattle

$543M37%

Dogs and Cats

$514M35%

Swine

$166M11%

Poultry

$122M8%

Horses

$47M3%

Fish

$39M3%

Sheep and Other

$21M1%